<it>Topoisomerase II alpha </it>gene copy loss has adverse prognostic significance in <it>ERBB2</it>-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts
<p>Abstract</p> <p>Background</p> <p>Amplification of the <it>ERBB2 </it>(<it>Her-2/neu</it>) oncogene, which occurs in approximately 25% of breast carcinomas, is a known negative prognostic factor. Available data indicate that a variable number...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-08-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/1/1/12 |